Ajanta Pharma USA Inc — Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
Official product recall notices and clearly labeled enforcement reference records.
Reference record — not a live warning · enforcement-reference · official-source
Failed Dissolution Specifications: below specification
- Posted by source
- Source last updated
- Current version retrieved
- Provider
- FDA — drug enforcement reference
- Location
- Bridgewater, NJ, US
- hazard
- Failed Dissolution Specifications: below specification
- notice
- Periodic enforcement reference; not a real-time safety alert or a reliable recall-lifecycle tracker.
- product
- Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
- distribution
- Nationwide in the US.
- manufacturer
- Ajanta Pharma USA Inc
- recall number
- D-0010-2027
- source status
- Ongoing
- classification
- Class II
- freshness minutes
- 180
Source use policy · openFDA reference data; not a real-time public alert service
Update history (1 recent revisions)
Report a correction · Related news · Fire information · Clips